Innovative medicines in the pipeline
Only 5 % of rare diseases have approved medicines. The need for innovative treatments is, therefore, high. A strong pipeline and expanded access are key elements of our commitment to patients.
Q3 report
Sobi intends to publish its report on 24th of October.
Press releases
A new therapy’s path to the patient
Bringing new therapies to patients involves navigating long timelines and inherent risks, making it a complex and costly endeavor. Discover how we prioritise patient access to treatment while addressing these development challenges.
Focus on Rare Diseases
More than 7,000 rare diseases have been identified, with more being discovered every day. While many rare diseases are very uncommon, together they affect 350 million people worldwide.
Our stories
At Sobi, we are dedicated to transforming the lives of people with rare and debilitating diseases. Meet some of the people who inspire us.
Their real-life experiences and stories reinforce our commitment to patients.
Head office
Careers
Take a look at our job opportunities.